Alphamab Oncology (FRA:3NK)
Germany · Delayed Price · Currency is EUR 1.170
+0.040 (3.54%)
At close: Nov 27, 2025
Alphamab Oncology Market Cap
Alphamab Oncology has a market cap or net worth of €1.12 billion as of December 1, 2025. Its market cap has increased by 134.60% in one year.
Market Cap
1.12B
Enterprise Value
952.63M
Revenue
93.42M
Ranking
n/a
PE Ratio
40.42
Stock Price
€1.17
Market Cap Chart
Since December 12, 2019, Alphamab Oncology's market cap has decreased from 1.40B to 1.12B, a decrease of -19.83%. That is a compound annual growth rate of -3.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 1.12B | 167.06% |
| Dec 31, 2024 | 418.85M | -43.55% |
| Dec 29, 2023 | 741.95M | -39.08% |
| Dec 30, 2022 | 1.22B | -15.24% |
| Dec 31, 2021 | 1.44B | -10.46% |
| Dec 31, 2020 | 1.60B | 11.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |